Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2026 12:00 ET | Source: 23andMe Research Institute

New 23andMe Research Institute Study First to Identify Association Between Specific Side Effects from Common Antidepressants and Genetics

New 23andMe study of 114,000+ people links CYP2C19 gene variants to SSRI side effects like sexual dysfunction and poor sleep.
July 22, 2026 09:00 ET | Source: D S Simon

Walmart Pharmacist Helps Patients Navigate the New Medicare GLP-1 Bridge Program With YourUpdateTV

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Millions of Medicare beneficiaries can now access GLP-1 weight loss medication with a co-pay of $50 a month through the new Medicare GLP-1 Bridge Program....
July 07, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global Infant Medicine Syringes Market Size/Share Worth USD 1108.13 Million by 2035 at a 5.89% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Infant Medicine Syringes Market Size, Trends and Insights By Type (Oral Syringes,...
July 03, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 03, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Antidiabetic Drugs Market Size, Trends, and Insights By Drug Class (Insulin,...
May 12, 2026 02:00 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity

Higher-dose Wegovy led to up to 28% weight loss, mainly from fat, with muscle preserved, new trial data show.
April 02, 2026 10:11 ET | Source: Visory Health

Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications

ESTERO, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the way Veterans, families and caregivers access affordable...
March 13, 2026 13:15 ET | Source: Cohen Milstein Sellers & Toll PLLC

Eve-of-Trial $65M Settlement Preliminarily Approved in Novel Antitrust Class Action Against J&J Subsidiary Actelion Pharmaceuticals

Plaintiffs alleged the anticompetitive scheme forced Tracleer purchasers to pay higher prices and delayed market entry of less-costly generic versions.
March 12, 2026 07:00 ET | Source: Tilray Brands, Inc.

Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with “gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany

DENSBORN, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), has announced a strategic partnership with Tilray...
February 18, 2026 08:30 ET | Source: Cedar Gate Technologies

GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear

GLP-1 use up 67% as bariatric surgeries fall 13%; lower annual costs, but long-term benefits and adherence remain uncertain.
December 08, 2025 15:17 ET | Source: Lynch Carpenter

Morton Drug Company Data Breach Claims Investigated by Lynch Carpenter

PITTSBURGH, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Morton Drug Company (“MDC”),1 recently announced a cybersecurity incident, which impacted the personal information of over forty thousand individuals....